List of insiders holdings for Eton Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | BRYNJELSEN SEAN President & CEO | 2026-05-29 16:16:53 | 833,694 0 | 833,694 | Form 4 |
| 2 | Gruber James R. Chief Financial Officer | 2026-01-14 18:02:48 | 747,426 0 | 747,426 | Form 4 |
| 3 | Troutman William Wilson CFO and Secretary | 2022-02-28 16:32:31 | 671,200 0 | 671,200 | Form 4 |
| 4 | CASAMENTO CHARLES J Director | 2026-01-14 18:07:31 | 598,099 0 | 598,099 | Form 4 |
| 5 | MAIER PAUL V Director | 2026-01-14 18:06:42 | 580,749 0 | 580,749 | Form 4 |
| 6 | Adams Jennifer McKie Director | 2026-01-14 18:08:18 | 348,415 0 | 348,415 | Form 4 |
| 7 | Krempa David Chief Business Officer | 2026-05-27 18:28:36 | 281,740 0 | 281,740 | Form 4 |
| 8 | Erdogan-Trinkaus Ipek Chief Commercial Officer | 2026-01-14 18:05:48 | 273,612 0 | 273,612 | Form 4 |
| 9 | RIEDEL NORBERT G Director | 2026-04-22 16:40:35 | 67,155 157,145 | 224,300 | Form 4 |
| 10 | Opaleye Management Inc. 10% Owner | 2025-06-12 16:32:51 | 0 85,000 | 85,000 | Form 4 |
| 11 | Matthews Judith M. Chief Financial Officer | 2026-06-01 16:26:41 | 37,000 0 | 37,000 | Form 3 |
| 12 | BAUM MARK L Director | 2020-03-16 16:58:11 | 27,400 0 | 27,400 | Form 4 |
| 13 | HARROW HEALTH INC. 10% Owner | 2024-04-30 07:00:15 | 0 0 | 0 | Form 13D |